首页 | 本学科首页   官方微博 | 高级检索  
     

132例复发性肝细胞癌病例的生存分析
引用本文:沈柏用 Farges,O. 132例复发性肝细胞癌病例的生存分析[J]. 预防医学情报杂志, 2000, 16(2): 103-106
作者姓名:沈柏用 Farges  O
作者单位:[1]上海第二医科大学附属瑞金医院普外科,上海 [2]巴黎第七大学附属BEAUJON医院肝胆外科,巴黎
摘    要:
目的 研究肝癌复发后的不同治疗方法带来的预后生存的不同。方法 对271例肝癌切除后复发的132例患者复发情况进行分析,同时比较复发后不同治疗方法的结果。结果 67%的肿瘤复发位于肝内,而且其中近一半是局限性复发,这些病例经再次肝切除、经肝动脉插管化疗栓塞或经皮无水酒精注射治疗后,5年生存率可达30%。同时发现肝移植亦不失为一种好的方法。结论 对于复发性肝细胞肝癌积极的外科治疗可获好的疗效。

关 键 词:肝细胞肝癌 复发 治疗 生存分析

Analysis on the Survival in 132 Recurrent Cases of Hepatocelluar Carainoma
Shen Baiyong,Zheng Minghua,Li Jianwen et al. Analysis on the Survival in 132 Recurrent Cases of Hepatocelluar Carainoma[J]. Journal of Preventive Medicine Information, 2000, 16(2): 103-106
Authors:Shen Baiyong  Zheng Minghua  Li Jianwen et al
Affiliation:Shen Baiyong,Zheng Minghua,Li Jianwen et al.Ruijin Hospital,Shanghai Second Medical university.Shanghai 200025.
Abstract:
Objective To study the reasonable treatment in the recurrence of hepatocellular carcinoma(HCC.)Methoods 132 recurrent cases of hepatocellular carcinoma were analysized by the following factors (host condition,tumor characteristics and surgical procedures from Jan.1983 to Jan.1997), The different surgical treatments in these patients were compared simultaneously.Results 67% of the recurrence were exclusively intrahepatic and half recurrence were limitited in size and number. The survival rate for 5 years was 30% following treatment of limited intrahepatic recurrence by re hepatectomy,arterial chemoembolization or percutaneous ethanol injection,and liver transplantation is needed to obtain better results.Conclusion An aggressive approach to tumor recurrence is the best way to improve the longterm outcome following resection of HCC.
Keywords:Hepatocellular Carcinoma  Recurrence  Treatment
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号